: iStockAnalyst.com Symbols Feed

Six Stocks That Fit Short Selling Patterns

Thu, 11 Sep 2008 17:40:00 GMT

This was sent to TIMalert subscribers waaaay early this morning:[More...]

Thirteen Penny Stocks That Are In Play

Tue, 09 Sep 2008 14:43:00 GMT

TIMlerts peeps got this at 1am this morn:Still no perfect setups, took me a decade, but I’ve got patience….if you’re gonna be a successful PennyStocker, you better learn patience too cuz there just aren’t great setups every day for big 20%+ predictable moves.UAUA took a big intraday dive on bankruptcy rumors/misinformation, someone’s gonna pay for that screw up…good news is some TIMalert peeps shorted and covered fro quick profit..I didn’t even think about it, I hate rumors and fast dives, I prefer fades…much better for TIMalert subscribers too, don’t wanna go short at the bottom and then find the stock halted, only to reopen up $5+!FNM/FRE donwtrended then bounced a bit…people wondering why don’t play em don’t have my PennyStocking DVD. People, I play pump and dumps[More...]

Eight Stocks which could be Setting Up

Mon, 08 Sep 2008 15:42:00 GMT

That’s right, no more posting my watchlist right at the market open…only TIMalert subscribers will get access as I emailed/posted this on the TIMalerts.com subscribers-only website this morning at 1am…in addition, that site is also gonna have a subscriber[More...]

Just 18 Stocks To Watch Today!

Mon, 09 Jun 2008 15:40:02 GMT

AAPL oh my god 3G is coming..developers conference…blehhhh..STFU you friggin geeks, I covered this stock last week, nothing’s changed[More...]

Earnings Summary for 01-24-2008

Fri, 25 Jan 2008 07:10:33 GMT

Ticker: ESIO,BPOP,LEN,LRCX,MNRO,SNV,CBON,OCFC,WBS,GY,BKUNA,FZN,HFWA,ABC,ABI,ALDN,ALK,AMGN,AMP,ARBA,AVCT,AVT,AVX,BARI,BAX,BDX,BEN,BHLB,BLL,BOFL,BRCM,CADE,CBE,CCMP,CMCO,CNXT,COL,COLB,CPS,CPWR,CRA,CSH,CVCO,CVTI,CY,CYN,DDE,DHR,DLX,DVD,ED,ELX,EMN,EPAY,ESI,ESSA[More...]

Pharmacyclics Secures $1.4 Million in Private Financing

Fri, 20 Feb 2009 19:00:58 GMT

Pharmacyclics has announced the close of a financing in connection with an investment by the principals of Pacific Biopharma Group (PBG), located in San Bruno California and Taizhou, Jiangsu Province, People's Republic of China.[More...]

Pharmacyclics, Inc. Rights Offering Oversubscribed

Wed, 05 Aug 2009 11:57:00 GMT

Pharmacyclics, Inc. announced today the preliminary results of its rights offering to purchase up to 22,500,000 shares of the Company's common stock at a subscription price of $1.28 per share, which expired as of 5:00 p.m., EDT, on July 31, 2009. The Company increased the offering size on July 29, 2009 by 3,750,000 shares, from up to 18,750,000 shares to up to 22,500,000 shares.[More...]

Pharmacyclics Announces Subscription Price for Rights Offering

Thu, 16 Jul 2009 00:45:00 GMT

SUNNYVALE, Calif., July 15 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (the "Company") announced today that it has set a subscription price of $1.28 per share of its common stock for its previously announced rights offering.
The Company previously announced the rights offering will be open to all stockholders of record as of July 15, 2009 (the "Record Date").
Shares of the Company's common stock that are not subscribed for under the basic subscription rights will be offered to each rights holder that exercises its basic subscription rights in full at the same purchase price per share, as provided in the prospectus.

[More...]

Pharmacyclics Sets Record Date for Rights Offering

Tue, 07 Jul 2009 17:23:00 GMT

Pharmacyclics, Inc. announced today that it has set the close of trading on July 15, 2009 as the record date for its upcoming Rights Offering. To participate in the rights offering, shares of Pharmacyclics would have to be purchased on or before July 10, 2009, assuming a three day settlement period.[More...]

Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference

Fri, 05 Jun 2009 18:10:00 GMT

Pharmacyclics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated disease and cancer, today announced that Glenn Rice, President and COO will present on Wednesday, June 10, at 11:30 a.m. ET at the 8th Annual Needham Life Sciences Conference taking place at the New York Palace Hotel.[More...]

Pharmacyclics Files Registration Statement for Rights Offering

Mon, 01 Jun 2009 11:50:00 GMT

SUNNYVALE, Calif., June 1 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it filed a registration statement on Form S-3 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing stockholders.
The net proceeds will be used for general working capital purposes, including the repayment of certain indebtedness of Pharmacyclics under an existing promissory note in favor of Robert W. Duggan, our Chairman of the Board and Chief Executive Officer, and the beneficial owner of approximately 27% of Pharmacyclics' outstanding common stock.
The reason the company decided to raise up to $24 million in this offering was to ensure that in the event other shareholders chose not to exercise their rights, Mr. Duggan would still be able to participate up to his proportionate 27% interest and provide Pharmacyclics with sufficient capital to satisfy the $6.4 million note payable to Mr. Duggan.

[More...]